UH Cleveland Medical Center (0 mi.)
11100 Euclid Ave
Cleveland, OH 44106
UH Ahuja Medical Center (5 mi.)
1000 Auburn Dr
Beachwood, OH 44122
Biography: Tiffany Hodges, MD
Certifications & Memberships
- Neurological Surgery - American Board of Neurological Surgery
Fellowship | Neurosurgical Oncology
Neurosurgical Oncology - University Of Texas Md Anderson Cancer Center (2015 - 2017)
Residency | Neurological Surgery
Neurological Surgery - Duke University Medical Center (2009 - 2015)
Duke University School Of Medicine (2005 - 2009)
Emory University (2005)
Tiffany Hodges, MD, FAANS, is an Associate Professor of Neurosurgery at University Hospitals Cleveland Medical Center, subspecializing in neurosurgical oncology. She is the Surgical Director of the Brain Tumor NeuroOncology Center.
Dr. Hodges received her bachelor's degree in neuroscience and behavioral biology from Emory University in 2005, graduating summa cum laude as an Emory Scholar. She completed her medical degree and neurosurgical residency training at Duke University, where she became a member of Alpha Omega Alpha Honor Society and was a Dean’s Scholar. Dr. Hodges then completed a neurosurgical oncology fellowship at MD Anderson Cancer Center, where her research focused on brain tumor immunotherapy and clinical trial development for patients with malignant gliomas and brain metastasis.
Her current research interests are brain tumor clinical trial development, brain tumor epidemiolog, and clinical outcomes after treatment. Dr. Hodges has published several articles and book chapters. She currently serves on the Executive Committee on the Congress of Neurological Surgeons and is an active member of the Society of NeuroOncology and the American Association of Neurological Surgeons.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Tiffany Hodges did not disclose any Outside Relationships with Industry.